<DOC>
	<DOCNO>NCT00841230</DOCNO>
	<brief_summary>The purpose study investigate whether increase tinnitus reduction obtain Deanxit patient already receive Rivotril .</brief_summary>
	<brief_title>Deanxit Rivotril Tinnitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>pure tone , narrow band noise polyphonic tinnitus unilateral bilateral tinnitus VAS ≥ 4 cochleair origin tinnitus tinnitus present 3 month age 18y intake Rivotril 1mg/d patient 'able cooperate ' patient able fill TQ en VAS No pontine angle pathology MRI pulsatile tinnitus pregnancy breast feed contraindication Deanxit recovery myocard infarct conduction disorder His untreated glaucoma MAO inhibitor : 15d stop otosclerosis middle ear pathology Ménière somatic tinnitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Tinnitus</keyword>
</DOC>